KR100931916B1 - 10,11-디히드로-10-히드록시-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드 및10,11-디히드로-10-옥소-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드의 제조방법 - Google Patents

10,11-디히드로-10-히드록시-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드 및10,11-디히드로-10-옥소-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드의 제조방법 Download PDF

Info

Publication number
KR100931916B1
KR100931916B1 KR1020037015323A KR20037015323A KR100931916B1 KR 100931916 B1 KR100931916 B1 KR 100931916B1 KR 1020037015323 A KR1020037015323 A KR 1020037015323A KR 20037015323 A KR20037015323 A KR 20037015323A KR 100931916 B1 KR100931916 B1 KR 100931916B1
Authority
KR
South Korea
Prior art keywords
dihydro
dibenz
carboxamide
azepine
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037015323A
Other languages
English (en)
Korean (ko)
Other versions
KR20040030626A (ko
Inventor
리어먼쓰데이비드알렉산더
Original Assignee
바이알 - 포르텔라 앤드 씨에이 에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이알 - 포르텔라 앤드 씨에이 에스에이 filed Critical 바이알 - 포르텔라 앤드 씨에이 에스에이
Publication of KR20040030626A publication Critical patent/KR20040030626A/ko
Application granted granted Critical
Publication of KR100931916B1 publication Critical patent/KR100931916B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
KR1020037015323A 2001-05-25 2002-05-22 10,11-디히드로-10-히드록시-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드 및10,11-디히드로-10-옥소-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드의 제조방법 Expired - Fee Related KR100931916B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0112812.3 2001-05-25
GBGB0112812.3A GB0112812D0 (en) 2001-05-25 2001-05-25 Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
PCT/GB2002/002356 WO2002096881A1 (en) 2001-05-25 2002-05-22 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide

Publications (2)

Publication Number Publication Date
KR20040030626A KR20040030626A (ko) 2004-04-09
KR100931916B1 true KR100931916B1 (ko) 2009-12-15

Family

ID=9915332

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037015323A Expired - Fee Related KR100931916B1 (ko) 2001-05-25 2002-05-22 10,11-디히드로-10-히드록시-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드 및10,11-디히드로-10-옥소-5Ｈ-디벤즈/ｂ,ｆ/아제핀-5-카르복스아미드의 제조방법

Country Status (23)

Country Link
US (1) US7241886B2 (enExample)
EP (2) EP1958938B1 (enExample)
JP (3) JP4323309B2 (enExample)
KR (1) KR100931916B1 (enExample)
CN (2) CN101172967A (enExample)
AR (1) AR035460A1 (enExample)
AT (2) ATE400560T1 (enExample)
AU (2) AU2002307863B8 (enExample)
BR (1) BR0210019A (enExample)
CA (2) CA2750876C (enExample)
CY (3) CY1108345T1 (enExample)
CZ (1) CZ303130B6 (enExample)
DE (2) DE60227517D1 (enExample)
DK (2) DK1399424T3 (enExample)
ES (2) ES2362688T3 (enExample)
GB (1) GB0112812D0 (enExample)
HU (1) HU230019B1 (enExample)
LU (1) LU91603I2 (enExample)
MX (1) MXPA03010793A (enExample)
PL (1) PL215305B1 (enExample)
RU (2) RU2311411C2 (enExample)
SI (1) SI1399424T1 (enExample)
WO (1) WO2002096881A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
ITMI20042230A1 (it) 2004-11-19 2005-02-19 Farchemia Srl Procedimento per la preparazione della 10,11-diidro-10 idrossi-5h-dibenz-b,f-azepin-5carbossiammide
ITMI20042291A1 (it) 2004-11-26 2005-02-26 Farchema S R L Procedimento per la preparazione della -s-piu-10,11-diidro-10-idrossi-5h-dibenz-b,f-azepin-5-carbossiammide
GB2422149A (en) * 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CA2769181C (en) 2009-07-27 2017-11-28 Bial-Portela & Ca., S.A. Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
WO2013008194A2 (en) 2011-07-13 2013-01-17 Ranbaxy Laboratories Limited Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof
IN2015DN02296A (enExample) 2012-09-26 2015-08-21 Ranbaxy Lab Ltd
DK3350343T3 (da) 2015-09-16 2020-07-20 Petaomics Inc Fremgangsmåder og sammensætninger til genommålberigelse og selektiv dna-sekventering
US12492423B2 (en) 2015-09-16 2025-12-09 PetaOmics, Inc. Methods and compositions for genomic target enrichment and selective DNA sequencing
CN111943347B (zh) * 2020-07-16 2022-08-30 同济大学 一种铜离子活化过氧乙酸去除废水中卡马西平的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5439390B2 (enExample) * 1971-09-30 1979-11-27
BE789320A (fr) * 1971-09-30 1973-03-27 Takeda Chemical Industries Ltd Derives de dibenzoxirenazepine
CH633271A5 (en) 1978-04-18 1982-11-30 Ciba Geigy Ag Process for the rearrangement of 10,11-epoxy-10,11-dihydro-5H-dibenz[b,f]azepines to give 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepines
CH642950A5 (en) * 1979-10-30 1984-05-15 Ciba Geigy Ag Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) * 1996-05-27 1999-09-30 Portela & Ca Sa Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
AT408224B (de) 1999-03-15 2001-09-25 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von oxcarbazepin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of medicinal chemistry, Vol 16(6), pp 703-705

Also Published As

Publication number Publication date
GB0112812D0 (en) 2001-07-18
ATE400560T1 (de) 2008-07-15
CN101172967A (zh) 2008-05-07
DK1399424T3 (da) 2008-09-08
RU2449992C2 (ru) 2012-05-10
US20040158060A1 (en) 2004-08-12
JP2009167194A (ja) 2009-07-30
RU2311411C2 (ru) 2007-11-27
HUP0400296A3 (en) 2008-03-28
PL366993A1 (en) 2005-02-07
BR0210019A (pt) 2004-08-10
JP2009057376A (ja) 2009-03-19
DE60227517D1 (de) 2008-08-21
CA2750876A1 (en) 2002-12-05
CY1108345T1 (el) 2012-01-25
EP1958938A3 (en) 2008-09-03
RU2007120532A (ru) 2008-12-10
EP1958938A2 (en) 2008-08-20
CZ303130B6 (cs) 2012-04-18
CN1511141B (zh) 2011-06-08
AU2002307863B2 (en) 2007-09-27
ES2305299T3 (es) 2008-11-01
AR035460A1 (es) 2004-05-26
CY1111492T1 (el) 2015-08-05
CY2009017I1 (el) 2012-01-25
AU2002307863B8 (en) 2007-10-18
DE60239842D1 (de) 2011-06-01
CY2009017I2 (el) 2012-01-25
EP1399424B8 (en) 2008-10-01
CN1511141A (zh) 2004-07-07
WO2002096881A1 (en) 2002-12-05
JP2004532263A (ja) 2004-10-21
ATE506351T1 (de) 2011-05-15
HU230019B1 (hu) 2015-05-28
ES2362688T3 (es) 2011-07-11
JP5280252B2 (ja) 2013-09-04
SI1399424T1 (sl) 2008-10-31
AU2007221834A1 (en) 2007-10-25
CA2448094C (en) 2011-11-01
LU91603I2 (fr) 2009-10-28
RU2003137224A (ru) 2005-05-27
DK1958938T3 (da) 2011-07-25
CZ20033203A3 (cs) 2004-06-16
JP4323309B2 (ja) 2009-09-02
WO2002096881A8 (en) 2003-02-27
EP1399424B1 (en) 2008-07-09
US7241886B2 (en) 2007-07-10
EP1958938B1 (en) 2011-04-20
PL215305B1 (pl) 2013-11-29
MXPA03010793A (es) 2004-07-01
CA2750876C (en) 2014-10-28
CA2448094A1 (en) 2002-12-05
KR20040030626A (ko) 2004-04-09
AU2007221834B2 (en) 2009-02-05
EP1399424A1 (en) 2004-03-24
HUP0400296A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
JP5280252B2 (ja) １０，１１−ジヒドロ−１０−ヒドロキシ−５Ｈ−ジベンズ／ｂ，ｆ／アゼピン−５−カルボキシアミド及び１０，１１−ジヒドロ−１０−オキソ−５Ｈ−ジベンズ／ｂ，ｆ／アゼピン−５−カルボキシアミドの製造方法
AU2002307863A1 (en) Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide
RU2418789C2 (ru) СПОСОБ ПОЛУЧЕНИЯ 10,11-ДИГИДРО-10-ГИДРОКСИ-5Н-ДИБЕНЗ/b, f/АЗЕПИН-5-КАРБОКСАМИДА

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20121208

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20121208